Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Keratosis, Actinic × Isotretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 40 Lung Neoplasms 4 Leukemia, Myelomonocytic, Juvenile 4 Ganglioneuroblastoma 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Medulloblastoma 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Gliosarcoma 3 Glioma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, Large B-Cell, Diffuse 2 HIV Infections 2 Burkitt Lymphoma 2

Interventions

3-ingenyl angelate 37 Aminolevulinic Acid 29 Imiquimod 24 Fluorouracil 22 Photochemotherapy 21 Gels 12 Cryotherapy 12 Diclofenac 11 methyl 5-aminolevulinate 10 tirbanibulin 6 calcipotriene 5 Solutions 5 Petrolatum 5 Ointments 5 LEO 43204 5 Radiotherapy 4 Prilocaine 4 Lidocaine 4 BF-200 ALA 4 Therapeutics 3 Niacinamide 3 Cryosurgery 3 1-phenyl-3,3-dimethyltriazene 3 SR-T100 2 Phototherapy 2 Imipramine 2 Deoxyribonuclease (Pyrimidine Dimer) 2 Celecoxib 2 tazarotene 1 potassium dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278861 2014-10-30

ARISOAK

Universidade Federal de Goias

Phase 2 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡